These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32131689)

  • 61. Changes in Statin Adherence Following an Acute Myocardial Infarction Among Older Adults: Patient Predictors and the Association With Follow-Up With Primary Care Providers and/or Cardiologists.
    Hickson RP; Robinson JG; Annis IE; Killeya-Jones LA; Korhonen MJ; Cole AL; Fang G
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29051213
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Medical Therapy Utilization and Long-Term Outcomes Following Percutaneous Coronary Intervention: Five-Year Results From the Veterans Affairs Clinical Assessment, Reporting, and Tracking System Program.
    Xie JX; Gunzburger EC; Kaun L; Plomondon ME; Barón AE; Waldo SW; Virani SS; Maddox TM; Mavromatis K
    Circ Cardiovasc Qual Outcomes; 2019 Nov; 12(11):e005455. PubMed ID: 31665896
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Self-controlled case-series study to verify the effect of adherence to Beta-blockers in secondary prevention of myocardial infarction.
    Di Bartolomeo S; Marino M; Guastaroba P; Valent F; De Palma R
    J Am Heart Assoc; 2015 Jan; 4(1):e001575. PubMed ID: 25567050
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Hospital Variation in Adherence Rates to Secondary Prevention Medications and the Implications on Quality.
    Mathews R; Wang W; Kaltenbach LA; Thomas L; Shah RU; Ali M; Peterson ED; Wang TY
    Circulation; 2018 May; 137(20):2128-2138. PubMed ID: 29386204
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Impact of renin angiotensin system inhibitor on 3-year clinical outcomes in acute myocardial infarction patients with preserved left ventricular systolic function: a prospective cohort study from Korea Acute Myocardial Infarction Registry (KAMIR).
    Kim KH; Choi BG; Rha SW; Choi CU; Jeong MH;
    BMC Cardiovasc Disord; 2021 May; 21(1):251. PubMed ID: 34020593
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Encouraging trends in acute myocardial infarction survival in the oldest old.
    Tjia J; Allison J; Saczynski JS; Tisminetzky M; Givens JL; Lapane K; Lessard D; Goldberg RJ
    Am J Med; 2013 Sep; 126(9):798-804. PubMed ID: 23835196
    [TBL] [Abstract][Full Text] [Related]  

  • 67. It's Not Too Late to Improve Statin Adherence: Association Between Changes in Statin Adherence from Before to After Acute Myocardial Infarction and All-Cause Mortality.
    Hickson RP; Robinson JG; Annis IE; Killeya-Jones LA; Fang G
    J Am Heart Assoc; 2019 Apr; 8(7):e011378. PubMed ID: 30929542
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Optimizing prevention and guideline-concordant care in Montenegro.
    Knežević B; Musić L; Batrićević G; Bošković A; Bulatović N; Nenezić A; Vujović J; Kalezić M
    Int J Cardiol; 2016 Aug; 217 Suppl():S32-6. PubMed ID: 27381861
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Optimal pharmacological treatment and adherence to medication in secondary prevention of cardiovascular events in Spain: Results from the CAPS study.
    Cordero A; Rodriguez Padial L; Batalla A; López Barreiro L; Torres Calvo F; Castellano JM; Ruiz E; Bertomeu-Martínez V;
    Cardiovasc Ther; 2017 Apr; 35(2):. PubMed ID: 27957818
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prevalence, predictors, and outcomes of primary nonadherence after acute myocardial infarction.
    Jackevicius CA; Li P; Tu JV
    Circulation; 2008 Feb; 117(8):1028-36. PubMed ID: 18299512
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Sex differences in quality indicator attainment for myocardial infarction: a nationwide cohort study.
    Wilkinson C; Bebb O; Dondo TB; Munyombwe T; Casadei B; Clarke S; Schiele F; Timmis A; Hall M; Gale CP
    Heart; 2019 Apr; 105(7):516-523. PubMed ID: 30470725
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Present treatment of acute myocardial infarction in patients over 75 years--data from the Berlin Myocardial Infarction Registry (BHIR).
    Schuler J; Maier B; Behrens S; Thimme W
    Clin Res Cardiol; 2006 Jul; 95(7):360-7. PubMed ID: 16741630
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Adherence to guideline-recommended therapy is associated with decreased major adverse cardiovascular events and major adverse limb events among patients with peripheral arterial disease.
    Armstrong EJ; Chen DC; Westin GG; Singh S; McCoach CE; Bang H; Yeo KK; Anderson D; Amsterdam EA; Laird JR
    J Am Heart Assoc; 2014 Apr; 3(2):e000697. PubMed ID: 24721799
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Patients with coronary artery disease after acute myocardial infarction: effects of continuous enrollment in a structured Disease Management Program on adherence to guideline-recommended medication, health care expenditures, and survival.
    Kirsch F; Becker C; Schramm A; Maier W; Leidl R
    Eur J Health Econ; 2020 Jun; 21(4):607-619. PubMed ID: 32006188
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Association of Diabetes Mellitus Status and Glycemic Control With Secondary Prevention Medication Adherence After Acute Myocardial Infarction.
    Adamek KE; Ramadurai D; Gunzburger E; Plomondon ME; Ho PM; Raghavan S
    J Am Heart Assoc; 2019 Feb; 8(3):e011448. PubMed ID: 30712488
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Trends in Gender Differences in Cardiac Care and Outcome After Acute Myocardial Infarction in Western Sweden: A Report From the Swedish Web System for Enhancement of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART).
    Redfors B; Angerås O; Råmunddal T; Petursson P; Haraldsson I; Dworeck C; Odenstedt J; Ioaness D; Ravn-Fischer A; Wellin P; Sjöland H; Tokgozoglu L; Tygesen H; Frick E; Roupe R; Albertsson P; Omerovic E
    J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26175358
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Community health worker-based intervention for adherence to drugs and lifestyle change after acute coronary syndrome: a multicentre, open, randomised controlled trial.
    Xavier D; Gupta R; Kamath D; Sigamani A; Devereaux PJ; George N; Joshi R; Pogue J; Pais P; Yusuf S
    Lancet Diabetes Endocrinol; 2016 Mar; 4(3):244-253. PubMed ID: 26857999
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A polypill strategy to improve adherence: results from the FOCUS project.
    Castellano JM; Sanz G; Peñalvo JL; Bansilal S; Fernández-Ortiz A; Alvarez L; Guzmán L; Linares JC; García F; D'Aniello F; Arnáiz JA; Varea S; Martínez F; Lorenzatti A; Imaz I; Sánchez-Gómez LM; Roncaglioni MC; Baviera M; Smith SC; Taubert K; Pocock S; Brotons C; Farkouh ME; Fuster V
    J Am Coll Cardiol; 2014 Nov 18-25; 64(20):2071-82. PubMed ID: 25193393
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effects of adherence to pharmacological secondary prevention after acute myocardial infarction on health care costs - an analysis of real-world data.
    Kirsch F; Becker C; Kurz C; Schwettmann L; Schramm A
    BMC Health Serv Res; 2020 Dec; 20(1):1145. PubMed ID: 33342431
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Drug Adherence and Long-Term Outcomes in Non-Revascularized Patients Following Acute Myocardial Infarction.
    Khan R; Kaul P; Islam S; Savu A; Bagai A; van Diepen S; Bainey KR; Welsh RC; Goodman SG
    Am J Cardiol; 2021 Aug; 152():49-56. PubMed ID: 34120704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.